药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Arbutamine
Isocarboxazid
The metabolism of Flibanserin can be decreased when combined with Isocarboxazid.
Arbutamine
Moclobemide
The metabolism of Flibanserin can be decreased when combined with Moclobemide.
Arbutamine
Procarbazine
The metabolism of Flibanserin can be decreased when combined with Procarbazine.
Arbutamine
Metergoline
Metergoline may increase the vasoconstricting activities of Flibanserin.
Arbutamine
Terguride
Terguride may increase the vasoconstricting activities of Flibanserin.
Arbutamine
Dihydroergocryptine
Dihydroergocryptine may increase the vasoconstricting activities of Flibanserin.
Arbutamine
Dihydroergocristine
Dihydroergocristine may increase the vasoconstricting activities of Flibanserin.
Arbutamine
Dihydroergocornine
Dihydroergocornine may increase the vasoconstricting activities of Flibanserin.
Arbutamine
Lysergic acid diethylamide
Lysergic acid diethylamide may increase the vasoconstricting activities of Flibanserin.
Arbutamine
Pergolide
Pergolide may increase the vasoconstricting activities of Flibanserin.
Arbutamine
Remimazolam
The risk or severity of adverse effects can be increased when Flibanserin is combined with Remimazolam.
Arbutamine
Bromperidol
The risk or severity of adverse effects can be increased when Flibanserin is combined with Bromperidol.
Arbutamine
Lemborexant
The risk or severity of adverse effects can be increased when Flibanserin is combined with Lemborexant.
Arbutamine
Tianeptine
The risk or severity of adverse effects can be increased when Flibanserin is combined with Tianeptine.
Arbutamine
Lurasidone
The risk or severity of adverse effects can be increased when Flibanserin is combined with Lurasidone.
Arbutamine
Fosphenytoin
The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Flibanserin.
Arbutamine
Levacetylmethadol
The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Flibanserin.
Arbutamine
Carfentanil, C-11
The risk or severity of adverse effects can be increased when Flibanserin is combined with Carfentanil, C-11.
Arbutamine
JNJ-26489112
The risk or severity of adverse effects can be increased when Flibanserin is combined with JNJ-26489112.
Arbutamine
Bentazepam
The risk or severity of adverse effects can be increased when Flibanserin is combined with Bentazepam.